In the backstretch of a business transformation that has consolidated their nationwide business and resumed shareholder dividends, one small cap Managing Director is so confident in the progress that he has personally backed the Company’s growth, purchasing $1.0 million in shares. The show of confidence comes from Dr Chris Richards, Managing Director and CEO of
Read More
As Australia has continued its love affair with pet ownership which surged during the pandemic as a means of companionship, Apiam Animal Health (ASX: AHX) has continued to benefit from the trend across its 80 veterinary clinics across regional Australia, highlighted by a 22.6% increase in revenue across FY23. The boost delivered $192.8 million revenue
Read More
Following the successful strategy employed in Queensland with their dedicated equine hub and support clinics, Apiam Animal Health (ASX: AHX) has set fresh foundations for growth in New South Wales with the acquisition of Agnes Banks Equine Clinic which will form the cornerstone of their operations in the State. Already Australia’s largest provider of regional
Read More
The US Environmental Protection Agency has granted regulatory label approval for the commercialisation of Xtend 21®– an innovative product that has been demonstrated by university studies to enhance long term antimicrobial surface protection. The pathway of Xtend 21® for the US market first commenced in March 2020 when Apiam Animal Health (ASX: AHX) was appointed the exclusive
Read More